Skip to main content

French Anderson sentenced to 14 years

French Anderson was sentenced today (Feb 2) to 14 years in prison, after he was linkurl:found guilty;https://www.the-scientist.com/news/display/23996/ last summer of four counts of molestation. His victim, now 19 years old, is the daughter of his colleague, and the abuse started when she was 10 years old. Soon after the conviction, the University of Southern California (USC) released a statement that it had suspended Anderson and was initiating dismissal proceedings to remove his tenure and fac

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
French Anderson was sentenced today (Feb 2) to 14 years in prison, after he was linkurl:found guilty;https://www.the-scientist.com/news/display/23996/ last summer of four counts of molestation. His victim, now 19 years old, is the daughter of his colleague, and the abuse started when she was 10 years old. Soon after the conviction, the University of Southern California (USC) released a statement that it had suspended Anderson and was initiating dismissal proceedings to remove his tenure and faculty position, calling his actions a "grave offense" to the USC community. Anderson linkurl:claimed;https://www.the-scientist.com/article/display/22328/ to have led the first team to carry out an approved human gene therapy clinical protocol, in September 1990. During the treatment, Anderson and his colleagues used a retrovirus to insert genes into the T lymphocytes of a 4-year-old girl suffering from severe combined immunodeficiency, or SCID, caused by a deficiency in the adenosine deaminase gene. Anderson had focused his recent research on gene therapy delivery systems. Before joining the University of Southern California, Anderson spent 27 years as a gene therapy researcher at the National Heart, Lung, and Blood Institute at the National Institutes of Health. To date, Anderson has published almost 400 research articles and been profiled by a number of publications, including the New York Times and Scientific American. See The Scientist daily news on Monday for more coverage.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo